Benjamin Noll - Search Results

Year	Number of Results
2010	1
2011	2
2013	2
2014	1
2016	1
2017	2
2018	1
2019	3
2020	1
2021	4
2022	1
2023	1
2024	0

1

Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition.

Islam S, Rahaman MH, Yu M, Noll B, Martin JH, Wang S, Head R. Islam S, et al. Among authors: noll b. Cancers (Basel). 2023 Feb 7;15(4):1044. doi: 10.3390/cancers15041044. Cancers (Basel). 2023. PMID: 36831387 Free PMC article.

2

An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia.

Anshabo AT, Bantie L, Diab S, Lenjisa J, Kebede A, Long Y, Heinemann G, Karanjia J, Noll B, Basnet SKC, Li M, Milne R, Albrecht H, Wang S. Anshabo AT, et al. Among authors: noll b. Cancers (Basel). 2022 Feb 22;14(5):1113. doi: 10.3390/cancers14051113. Cancers (Basel). 2022. PMID: 35267421 Free PMC article.

3

Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838].

Bantie L, Tadesse S, Likisa J, Yu M, Noll B, Heinemann G, Lokman NA, Ricciardelli C, Oehler MK, Beck A, Pradhan R, Milne R, Albrecht H, Wang S. Bantie L, et al. Among authors: noll b. Gynecol Oncol. 2021 Oct;163(1):215. doi: 10.1016/j.ygyno.2021.07.018. Epub 2021 Jul 31. Gynecol Oncol. 2021. PMID: 34340816 No abstract available.

4

Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation.

Yu M, Long Y, Yang Y, Li M, Teo T, Noll B, Philip S, Wang S. Yu M, et al. Among authors: noll b. Eur J Med Chem. 2021 Jun 5;218:113391. doi: 10.1016/j.ejmech.2021.113391. Epub 2021 Mar 26. Eur J Med Chem. 2021. PMID: 33823391

5

Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients.

Sallustio BC, Noll BD, Hu R, Barratt DT, Tuke J, Coller JK, Russ GR, Somogyi AA. Sallustio BC, et al. Among authors: noll bd. Br J Clin Pharmacol. 2021 Oct;87(10):3901-3909. doi: 10.1111/bcp.14806. Epub 2021 Mar 19. Br J Clin Pharmacol. 2021. PMID: 33646566 Free article.

6

Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.

Yu M, Teo T, Yang Y, Li M, Long Y, Philip S, Noll B, Heinemann GK, Diab S, Eldi P, Mekonnen L, Anshabo AT, Rahaman MH, Milne R, Hayball JD, Wang S. Yu M, et al. Among authors: noll b. Eur J Med Chem. 2021 Mar 15;214:113248. doi: 10.1016/j.ejmech.2021.113248. Epub 2021 Feb 3. Eur J Med Chem. 2021. PMID: 33571827

7

A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer.

Bantie L, Tadesse S, Likisa J, Yu M, Noll B, Heinemann G, Lokman NA, Ricciardelli C, Oehler MK, Beck A, Pradhan R, Milne R, Albrecht H, Wang S. Bantie L, et al. Among authors: noll b. Gynecol Oncol. 2020 Dec;159(3):827-838. doi: 10.1016/j.ygyno.2020.09.012. Epub 2020 Sep 18. Gynecol Oncol. 2020. PMID: 32958271

8

Sulfonamide-Based Inhibitors of Biotin Protein Ligase as New Antibiotic Leads.

Lee KJ, Tieu W, Blanco-Rodriguez B, Paparella AS, Yu J, Hayes A, Feng J, Marshall AC, Noll B, Milne R, Cini D, Wilce MCJ, Booker GW, Bruning JB, Polyak SW, Abell AD. Lee KJ, et al. Among authors: noll b. ACS Chem Biol. 2019 Sep 20;14(9):1990-1997. doi: 10.1021/acschembio.9b00463. Epub 2019 Aug 21. ACS Chem Biol. 2019. PMID: 31407891

9

Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantation.

Sallustio BC, Noll BD, Coller JK, Tuke J, Russ G, Somogyi AA. Sallustio BC, et al. Among authors: noll bd. Br J Clin Pharmacol. 2019 May;85(5):1015-1020. doi: 10.1111/bcp.13880. Epub 2019 Mar 6. Br J Clin Pharmacol. 2019. PMID: 30690767 Free PMC article.

10

Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity.

Abdelaziz AM, Diab S, Islam S, Basnet SKC, Noll B, Li P, Mekonnen LB, Lu J, Albrecht H, Milne RW, Gerber C, Yu M, Wang S. Abdelaziz AM, et al. Among authors: noll b. Med Chem. 2019;15(6):602-623. doi: 10.2174/1573406415666181219111511. Med Chem. 2019. PMID: 30569866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year